ARCHIVES

Femara Better Suppressor Of Estrogen, Study Finds

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Shubik Group Finishes Criteria, Presents Final Draft To Rauscher

July 2, 1976

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983